Ingrid S. Kockum

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 193 publications

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Lymphocyte count polygenicity underlies dimethyl fumarate-associated lymphopenia in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 18, 2026

An AI-Health infrastructure for the Nordic region: technical foundations, data assets, and a roadmap for deployment.

An AI-Health infrastructure for the Nordic region: technical foundations, data assets, and a roadmap for deployment.

Journal: Nature medicine

Published: August 14, 2026

HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.

HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: April 06, 2026

CSF Proteins Associated With Neuroaxonal Damage in Early Active Multiple Sclerosis.

CSF Proteins Associated With Neuroaxonal Damage in Early Active Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: March 25, 2026

A susceptibility network analysis of disease trajectories leading to multiple sclerosis: A nationwide cohort study.

A susceptibility network analysis of disease trajectories leading to multiple sclerosis: A nationwide cohort study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 10, 2026

Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study.

Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 03, 2026

Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis.

Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis.

Journal: Clinical & translational immunology

Published: February 26, 2026

Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression.

Multi-omics integration provides biological insight and prioritizes potential drug targets in multiple sclerosis progression.

Journal: Journal of neuroinflammation

Published: November 05, 2025

Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis.

Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 15, 2025

Co-exposure to PFAS and hydroxylated PCBs is associated with increased odds of multiple sclerosis.

Co-exposure to PFAS and hydroxylated PCBs is associated with increased odds of multiple sclerosis.

Journal: Environment international

Published: September 09, 2025

A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis.

A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis.

Journal: Acta neuropathologica

Published: September 02, 2025

A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren's disease.

A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren's disease.

Journal: Annals of the rheumatic diseases

Published: July 12, 2025

Showing 1-12 of 193

Last Updated: 09/26/2026